{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T21:04:19Z","timestamp":1782421459119,"version":"3.54.5"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T00:00:00Z","timestamp":1555372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"publisher","award":["#1-17-IBS-290"],"award-info":[{"award-number":["#1-17-IBS-290"]}],"id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL136386"],"award-info":[{"award-number":["HL136386"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL088105"],"award-info":[{"award-number":["HL088105"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2019.00362","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T05:32:55Z","timestamp":1555392775000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":55,"title":["Canagliflozin Inhibits Human Endothelial Cell Proliferation and Tube Formation"],"prefix":"10.3389","volume":"10","author":[{"given":"Ghazaleh","family":"Behnammanesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zane E.","family":"Durante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly J.","family":"Peyton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis A.","family":"Martinez-Lemus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn B.","family":"Bender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Durante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,4,16]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1001\/jama.287.19.2570","article-title":"Diabetes and atherosclerosis: epidemiology, pathophysiology, and management","volume":"287","author":"Beckman","year":"2002","journal-title":"JAMA."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S2213-8587(17)30258-9","article-title":"Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): a multinational observational analysis","volume":"5","author":"Birkeland","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s12325-012-0055-3","article-title":"Pharmacokinetics of empagliflozin, a sodium glucose cotransporter-2 (SGLT-2) inhibitor, coadministered with sitagliptin in healthy volunteers","volume":"29","author":"Brand","year":"2012","journal-title":"Adv. Ther."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","article-title":"The pathobiology of diabetic complications","volume":"54","author":"Brownlee","year":"2005","journal-title":"Diabetes"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.redox.2017.01.007","article-title":"Angiogenesis in atherosclerotic plaque","volume":"12","author":"Camere","year":"2017","journal-title":"Redox Biol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.bcp.2013.11.002","article-title":"Heme oxygenase-1 counteracts contrast media-induced endothelial dysfunction","volume":"87","author":"Chang","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1161\/01.CIR.0000091257.27563.32","article-title":"Diabetes and vascular disease. Pathophysiology, clinical consequences, and medical therapy: part I","volume":"108","author":"Creager","year":"2003","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2147\/CPAA.S82008","article-title":"The treatment of type 2 diabetes in the presence of renal impairment: what should we know about the newer therapies","volume":"8","author":"Davies","year":"2016","journal-title":"Clin. Pharm."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/sj.bjp.0703393","article-title":"Endothelial dysfunction in diabetes","volume":"130","author":"De Vriese","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"438","DOI":"10.5414\/CP202324","article-title":"Pharmacokinetics and pharmacodynamics of once-and twice-daily multiple-doses of canagliflozin, a selective inhibitor of sodium glucose co-transporter 2, in healthy participants","volume":"53","author":"Devineni","year":"2015","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/j.1476-5381.1988.tb11548.x","article-title":"Impairment of endothelium-dependent relaxation in aortae from spontaneously diabetic rats","volume":"94","author":"Durante","year":"1988","journal-title":"Br. J. Pharmacol."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00418-004-0633-9","article-title":"Localization of the Na+\u2212 D-glucose cotransporter SGLT1\u00a0in the blood-brain barrier","volume":"121","author":"Elfeber","year":"2004","journal-title":"Histochem. Cell Biol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/S2213-8587(17)30257-7","article-title":"SGLT2 inhibitors and amputations in the US FDA adverse event reporting system","volume":"5","author":"Fadini","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2337\/diaclin.26.2.77","article-title":"Microvascular and macrovascular complications of diabetes","volume":"26","author":"Fowler","year":"2008","journal-title":"Clin. Diabetes"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"608","DOI":"10.2174\/1389200217666160406115959","article-title":"Medication-induced nephrotoxicity in older patients","volume":"17","author":"Fusco","year":"2016","journal-title":"Curr. Drug Metab."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.2337\/diacare.21.7.1138","article-title":"Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971\u20131993","volume":"21","author":"Gu","year":"1998","journal-title":"Diabetes Care"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/cvr\/cvr278","article-title":"Circulating endothelial progenitor cells do not contribute to regeneration of endothelium after murine injury","volume":"93","author":"Hagensen","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.2337\/db16-0058","article-title":"The Na+\/glucose cotransporter inhibitor canagliflozin activates AMPK by inhibiting mitochondrial function and increasing cellular AMP levels","volume":"65","author":"Hawley","year":"2016","journal-title":"Diabetes"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.15252\/embj.201695518","article-title":"Role of glutamine and interlinked asparagine metabolism in vessel formation","volume":"36","author":"Huang","year":"2017","journal-title":"EMBO J."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1002\/ijc.31193","article-title":"Sodium glucose cotransporter 2 inhibitor canagliflozin attenuates liver cancer cell growth and angiogenic activity by inhibiting glucose uptake","volume":"142","author":"Kaji","year":"2018","journal-title":"Int. J. Cancer"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s13300-014-0089-4","article-title":"Sodium glucose co-transporter 2 (SGLT2) inhibitors: a review of their basic and clinical pharmacology","volume":"5","author":"Kalra","year":"2014","journal-title":"Diabetes Ther."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/j.1463-1326.2011.01359.x","article-title":"Pharmacokinetics and pharmacodynamics of dapagliflozin, a novel selective inhibitor of sodium\u2013glucose co-transporter type 2, in Japanese subjects without and with type 2 diabetes mellitus","volume":"13","author":"Kasichayanula","year":"2011","journal-title":"Diabetes Obes. Metab."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1089\/ten.tec.2011.0150","article-title":"A comparison of methods for quantifying angiogenesis in the Matrigel assay in\u00a0vitro","volume":"17","author":"Khoo","year":"2011","journal-title":"Tissue Eng. Part C. Methods"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.yexcr.2004.06.032","article-title":"A versatile in\u00a0vitro assay for investigating angiogenesis of the heart","volume":"300","author":"Kiefer","year":"2004","journal-title":"Exp. Cell Res."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.15252\/embj.201796436","article-title":"Glutamine fuels proliferation but not migration of endothelial cells","volume":"36","author":"Kim","year":"2017","journal-title":"EMBO J."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.pharmthera.2013.04.003","article-title":"Ipragliflozin and other sodium-glucose cotransporter-2 (SGLT2) inhibitors in the treatment of type 2 diabetes: preclinical and clinical data","volume":"139","author":"Kurosaki","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"ref27","first-page":"e30555","article-title":"Effect of canagliflozin on renal threshold for glucose, glycemia, and body weight in normal and diabetic animal models","volume-title":"PLoS One","author":"Liang","year":"2012"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"H1634","DOI":"10.1152\/ajpheart.00872.2012","article-title":"Physiological cyclic strain promotes endothelial cell survival via the induction of heme oxygenase-1","volume":"304","author":"Liu","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"5276","DOI":"10.1038\/s41598-018-23420-4","article-title":"Canagliflozin inhibits interleukin-1\u03b2-stimulated cytokine and chemokine secretion in vascular endothelial cells by AMPK-activated protein kinase-depenent and independent mechanisms","volume":"8","author":"Mancini","year":"2018","journal-title":"Sci. Rep."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"978","DOI":"10.2337\/diab.36.8.978","article-title":"Endothelium-dependent relaxation in aorta of BB rat","volume":"36","author":"Meraji","year":"1987","journal-title":"Diabetes"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12933-018-0749-1","article-title":"Canagliflozin attenutates the progression of atherosclerosis and inflammation process in APOE knockout mice","volume":"17","author":"Nasiri-Ansari","year":"2018","journal-title":"Cardiovasc. Diabetol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N. Engl. J"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1124\/dmd.115.065870","article-title":"Inhibition of human UDP-glucuronosyltransferase enzymes by canagliflozin and dapagliflozin: implications for drug-drug interactions","volume":"43","author":"Pattanawongsa","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.bcp.2018.08.032","article-title":"Glutaminase-1 stimulates the proliferation, migration, and survival of human endothelial cells","volume":"156","author":"Peyton","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1124\/jpet.112.194712","article-title":"Activation of AMP-activated protein kinase inhibits the proliferation of human endothelial cells","volume":"342","author":"Peyton","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/ncpendmet0366","article-title":"Mechanisms of disease: endothelial dysfunction in insulin resistance and diabetes","volume":"3","author":"Rask-Madsen","year":"2007","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1146\/annurev.med.53.082901.103904","article-title":"Diabetes and cardiovascular disease","volume":"53","author":"Resnick","year":"2002","journal-title":"Annu. Rev. Med."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/2045-8118-11-8","article-title":"Impact of altered glycemia on blood-brain barrier endothelium: an in\u00a0vitro study using the hCMEC\/D3 cell line","volume":"11","author":"Sajja","year":"2014","journal-title":"Fluids Barrier CNS"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/BF02000821","article-title":"The effect of diabetes on the proliferation of aortic endothelial cells","volume":"6","author":"Santilli","year":"1992","journal-title":"Ann. Vasc. Surg."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"eaat5933","DOI":"10.1126\/scitranslmed.aat5933","article-title":"Sodium glucose transporter 2 is a diagnostic and therapeutic target for early stage lung adenocarcinoma","volume":"10","author":"Scafoglio","year":"2018","journal-title":"Sci. Transl. Med"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/s41419-018-0273-y","article-title":"Canagliflozin mediated dual inhibition of mitochondrial glutamate dehydrogenase and complex I: an off-target adverse effect","volume":"9","author":"Secker","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jacbts.2018.01.010","article-title":"Canagliflozin improves the recovery of blood flow in an experimental model of severe limb ischemia","volume":"3","author":"Sherman","year":"2018","journal-title":"JCC Basic Trans. Sci."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2174\/157339906775473671","article-title":"Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy","volume":"2","author":"Sim\u00f3","year":"2006","journal-title":"Curr. Diabetes Rev."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.2337\/dc12-1513","article-title":"All-cause and cardiovascular mortality in middle-aged people with type 2 diabetes compared with people without diabetes in a large U.K. primary care database","volume":"36","author":"Taylor","year":"2013","journal-title":"Diabetes Care"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.vph.2016.11.001","article-title":"Transendothelial glucose transport is not restricted by extracellular hyperglycaemia","volume":"87","author":"Tumova","year":"2016","journal-title":"Vasc. Pharmacol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1007\/s00125-017-4509-7","article-title":"Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na+\/H+ exchanger, lowering cytosolic Na+ and vasodilation","volume":"61","author":"Uthman","year":"2018","journal-title":"Diabetologia"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1056\/NEJM199007053230106","article-title":"Regulatory functions of the vascular endothelium","volume":"323","author":"Vane","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.molmet.2016.08.014","article-title":"The diabetes medication canagliflozin reduces cancer cell proliferation by inhibiting mitochondrial complex-I supported respiration","volume":"5","author":"Villani","year":"2016","journal-title":"Mol. Metab."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1161\/01.ATV.0000178991.71605.18","article-title":"Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage","volume":"25","author":"Virmani","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1007\/s00424-014-1619-7","article-title":"Localizations of Na(+)-D-glucose cotransporter SGLT1 and SGLT2\u00a0in human kidney and of SGLT1\u00a0in human small intestine, liver, lung, and heart","volume":"467","author":"Vrhovac","year":"2015","journal-title":"Pflugers Arch."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1182\/blood.V99.3.939","article-title":"Cyclin A transcriptional suppression is the major mechanism mediating homocysteine-induced endothelial cell growth inhibition","volume":"99","author":"Wang","year":"2002","journal-title":"Blood"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2004235","article-title":"A ligand-independent VEGFR2 signaling pathway limits angiogenic responses in diabetes","volume":"7","author":"Warren","year":"2014","journal-title":"Sci. Signal."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ccr.2008.03.015","article-title":"Survival of cancer cells is maintained by EGFR independent of its kinase activity","volume":"13","author":"Weihua","year":"2008","journal-title":"Cancer Cell"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/0092-8674(95)90385-2","article-title":"The retinoblastoma protein and cell cycle control","volume":"81","author":"Weinberg","year":"1995","journal-title":"Cell"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-1-59745-241-0_11","article-title":"Three-dimensional in-vitro angiogenesis in the rat aortic ring model","volume-title":"Angiogenesis protocols. 2nd Edn.","author":"West","year":"2009"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0735-1097(95)00522-6","article-title":"Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus","volume":"27","author":"Williams","year":"1996","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1161\/CIRCULATIONAHA.108.835223","article-title":"Molecular insights and therapeutic targets for diabetic endothelial dysfunction","volume":"120","author":"Xu","year":"2009","journal-title":"Circulation"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/j.jvs.2009.08.007","article-title":"Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: roles of endothelial nitric oxide synthase and endothelial progenitor cells","volume":"50","author":"Yan","year":"2009","journal-title":"J. Vasc. Surg."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00362\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T05:32:58Z","timestamp":1555392778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00362\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,16]]},"references-count":59,"alternative-id":["10.3389\/fphar.2019.00362"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2019.00362","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,16]]},"article-number":"362"}}